These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 26573807

  • 1. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
    Wittmann P, Grubinger M, Gröger C, Huber H, Sieghart W, Peck-Radosavljevic M, Mikulits W.
    BMC Cancer; 2015 Nov 16; 15():909. PubMed ID: 26573807
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug 16; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 3. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
    Liu Z, Zhang Y, Xu Z.
    J BUON; 2018 Aug 16; 23(1):185-187. PubMed ID: 29552781
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
    Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I.
    Cancer Lett; 2017 Apr 28; 392():39-50. PubMed ID: 28161507
    [Abstract] [Full Text] [Related]

  • 5. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.
    Hepatology; 2013 Oct 28; 58(4):1349-61. PubMed ID: 23696034
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
    Zhang S, Sun WY, Wu JJ, Gu YJ, Wei W.
    Oncol Rep; 2016 Apr 28; 35(4):2373-81. PubMed ID: 26882862
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY.
    Biomed Pharmacother; 2018 Feb 28; 98():214-221. PubMed ID: 29268242
    [Abstract] [Full Text] [Related]

  • 9. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z, Zhang Y, Xu Z.
    J BUON; 2018 Feb 28; 23(1):188-192. PubMed ID: 29552782
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
    Brockhausen J, Tay SS, Grzelak CA, Bertolino P, Bowen DG, d'Avigdor WM, Teoh N, Pok S, Shackel N, Gamble JR, Vadas M, McCaughan GW.
    Liver Int; 2015 Jan 28; 35(1):240-53. PubMed ID: 24576072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. P21-activated kinase-2 is a critical mediator of transforming growth factor-β-induced hepatoma cell migration.
    Sato M, Matsuda Y, Wakai T, Kubota M, Osawa M, Fujimaki S, Sanpei A, Takamura M, Yamagiwa S, Aoyagi Y.
    J Gastroenterol Hepatol; 2013 Jun 28; 28(6):1047-55. PubMed ID: 23425030
    [Abstract] [Full Text] [Related]

  • 15. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
    Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L.
    Cancer Lett; 2016 Aug 10; 378(2):80-6. PubMed ID: 27177473
    [Abstract] [Full Text] [Related]

  • 16. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
    Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, Huang XF, Chen ZN, Bian H.
    Oncogene; 2011 Oct 27; 30(43):4410-27. PubMed ID: 21532623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma.
    Xia H, Chen J, Shi M, Gao H, Sekar K, Seshachalam VP, Ooi LL, Hui KM.
    J Hepatol; 2015 Oct 27; 63(4):863-73. PubMed ID: 25980764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.